Nutex Health (NUTX) Revenue & Revenue Breakdown
Nutex Health Revenue Highlights
Latest Revenue (Y)
$875.26M
Latest Revenue (Q)
$210.75M
Main Segment (Y)
Hospital Division
Nutex Health Revenue by Period
Nutex Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $875.26M | 82.36% |
| 2024-12-31 | $479.95M | 93.80% |
| 2023-12-31 | $247.65M | 12.93% |
| 2022-12-31 | $219.29M | -33.85% |
| 2021-12-31 | $331.53M | 20.98% |
| 2020-12-31 | $274.03M | 182.34% |
| 2019-12-31 | $97.06M | 106120.79% |
| 2018-12-31 | $91.37K | 70.32% |
| 2017-12-31 | $53.65K | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | -100.00% |
| 2011-12-31 | $2.55M | 101.26% |
| 2010-12-31 | $1.27M | 474.39% |
| 2009-12-31 | $220.47K | - |
Nutex Health generated $875.26M in revenue during NA 2025, up 82.36% compared to the previous quarter, and up 319.40% compared to the same period a year ago.
Nutex Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $210.75M | -2.65% |
| 2026-03-31 | $216.49M | 42.73% |
| 2025-12-31 | $151.68M | -43.36% |
| 2025-09-30 | $267.80M | 9.76% |
| 2025-06-30 | $243.99M | 15.20% |
| 2025-03-31 | $211.79M | -17.79% |
| 2024-12-31 | $257.62M | 226.95% |
| 2024-09-30 | $78.79M | 3.57% |
| 2024-06-30 | $76.08M | 12.79% |
| 2024-03-31 | $67.45M | -3.18% |
| 2023-12-31 | $69.67M | 11.07% |
| 2023-09-30 | $62.72M | 6.45% |
| 2023-06-30 | $58.92M | 4.61% |
| 2023-03-31 | $56.33M | 4.85% |
| 2022-12-31 | $53.72M | 89.20% |
| 2022-09-30 | $28.40M | -51.08% |
| 2022-06-30 | $58.05M | -26.64% |
| 2022-03-31 | $79.13M | 24.80% |
| 2021-12-31 | $63.40M | -46.26% |
| 2021-09-30 | $117.97M | 87.81% |
| 2021-06-30 | $62.81M | 3018.37% |
| 2021-03-31 | $2.01M | -98.10% |
| 2020-12-31 | $106.13M | 30221.08% |
| 2020-09-30 | $350.03K | -7.54% |
| 2020-06-30 | $378.59K | -18.69% |
| 2020-03-31 | $465.63K | -78.36% |
| 2019-12-31 | $2.15M | 12129.14% |
| 2019-09-30 | $17.59K | 22.28% |
| 2019-06-30 | $14.39K | 6.32% |
| 2019-03-31 | $13.53K | -63.64% |
| 2018-12-31 | $37.22K | 22.35% |
| 2018-09-30 | $30.42K | 161.76% |
| 2018-06-30 | $11.62K | -4.14% |
| 2018-03-31 | $12.12K | -102.04% |
| 2017-12-31 | $-593.66K | -2301.67% |
| 2017-09-30 | $26.96K | 41.71% |
| 2017-06-30 | $19.03K | -97.31% |
| 2011-12-31 | $706.18K | 17.44% |
| 2011-09-30 | $601.31K | -13.98% |
| 2011-06-30 | $699.03K | 28.94% |
| 2011-03-31 | $542.12K | 9.93% |
| 2010-12-31 | $493.16K | - |
Nutex Health generated $210.75M in revenue during Q2 2026, up -2.65% compared to the previous quarter, and up 99.51% compared to the same period a year ago.
Nutex Health Revenue Breakdown
Nutex Health Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 |
|---|---|
| Hospital Division | $449.06M |
Latest
Nutex Health's latest annual revenue breakdown by segment (product or service), as of Dec 24: Hospital Division (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 26 | Mar 26 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 |
|---|---|---|---|---|---|---|---|
| Hospital Division | $201.85M | $207.57M | $260.24M | $236.30M | $203.95M | $377.33M | $71.73M |
Latest
Nutex Health's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Hospital Division (100.00%).
Nutex Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AMN | AMN Healthcare Services | $2.73B | $673.24M |
| EVH | Evolent Health | $1.88B | $652.52M |
| NUTX | Nutex Health | $875.26M | $210.75M |
| MYGN | Myriad Genetics | $824.50M | $190.70M |
| CDNA | CareDx | $379.81M | $131.95M |
| HSTM | HealthStream | $304.06M | $83.73M |
| DNA | Ginkgo Bioworks | $170.16M | $20.16M |
| PACB | Pacific Biosciences of California | $160.00M | $39.01M |
| DAWN | Day One Biopharmaceuticals | $158.18M | $39.80M |
| BFLY | Butterfly Network | $97.61M | $29.02M |
| REPL | Replimune Group | - | - |